— Know what they know.
Not Investment Advice

300171.SZ SHZ

Tofflon Science and Technology Group Co., Ltd.
1W: +3.9% 1M: +10.1% 3M: +41.0% YTD: +1.1% 1Y: +11.1% 3Y: -20.6% 5Y: -54.3%
¥16.43 ($2.45)
+0.53 (+3.33%)
 
SHZ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 68 · ¥12.5B mcap · 404M float · 3.71% daily turnover

Cash Flow Trends

Operating Cash Flow
$881M +371.8% ▲
5Y CAGR: +14.6%
Capital Expenditures
$499M +28.2% ▲
5Y CAGR: +104.2%
Free Cash Flow
$382M +137.5% ▲
5Y CAGR: -2.4%
Dividends Paid
$182M +26.9% ▲
Buybacks
$64M +0.0% ▲
Net Change in Cash
$196M +108.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$481M$886M$903M$600M$208M
Depreciation & Amort.$44M$46M$66M$90M$116M
Stock-Based Comp.$0$78M$53M$0$0
Change in Working Capital$543M$240M-$949M-$1.1B$389M
Other Non-Cash Items$47M$155M$196M$136M$167M
Operating Cash Flow$1.1B$1.4B$247M-$312M$881M
— Investing Activities —
Capital Expenditures-$27M-$454M-$726M-$695M-$499M
Acquisitions (Net)$32M-$51M-$42M$2M-$21M
Investment Purchases-$3.4B-$3.4B-$1.6B-$3.0B-$1.2B
Investment Sales$3.4B$3.4B$2.3B$1.8B$1.3B
Other Investing-$27M$343K-$3M$946K$3M
Investing Cash Flow$38M-$446M-$107M-$1.9B-$378M
— Financing Activities —
Net Debt Issuance$0-$2M$0-$7M$3M
Stock Repurchased$0$0$0$0-$64M
Dividends Paid-$44M-$138M-$245M-$249M-$182M
Other Financing-$9M-$69M$2.3B$32M-$55M
Financing Cash Flow-$106M-$209M$2.1B-$224M-$298M
Net Change in Cash$1.0B$686M$2.3B-$2.4B$196M
Cash End of Period$1.8B$2.5B$4.7B$2.3B$2.5B
Free Cash Flow$1.1B$915M-$479M-$1.0B$382M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms